In Midst Of Raucous Debate Over 340B Drug Discount Program, Lawmaker Introduces Bill To Address Concerns
The measure from Rep. Doris Matsui (D-Calif.) could clarify the intent of the program and define which patients are eligible -- two bones of contention over the program, which requires pharmaceutical companies to give steep discounts to hospitals and clinics that serve high volumes of low-income patients.
Stat:
A Bill Would Keep Status Quo Of Contentious Hospital Drug-Discount Program
Amid ongoing debate over a drug discount program for safety-net hospitals, a lawmaker introduced a bill that would memorialize the intent of the controversial program and require the Trump administration to implement oft-delayed regulations about pricing and penalties. The bill arrives as Congress hashes out oversight of the 340B program, which was created in 1992 and requires drug makers to offer discounts of up to 50 percent on all outpatient drugs — for everything from AIDS to diabetes — to hospitals and clinics that serve indigent populations. There are currently more than 12,400 such providers, according to the Human Resources and Services Administration. (Silverman, 6/13)
In other national health care news —
Stat:
The DEA Is Playing 'Whack-A-Mole' As It Tries To Stamp Out The Opioid Crisis
Four years ago, the Drug Enforcement Agency decided to make it harder to obtain the most commonly prescribed opioid painkillers — specifically, pills such as Vicodin that contain hydrocodone. The move worked: Prescriptions for hydrocodone-based opioids fell by a whopping 26 percent between June 2013 and June 2015. But the tactic appears to have created yet another problem — there has been a notable uptick in illicit trading of opioids on the “dark net,” according to a new study published in BMJ. (Silverman, 6/13)
The Washington Post:
Devastated By ALS, Trying To Save Others
Rahul Desikan sits at his dining room table, a large computer screen before him, and works on his latest scientific paper. He types a single letter, then another, then another. For a man in a hurry, desperately trying to rid the world of terrible diseases, it’s an excruciatingly slow process. Using a special mouse strapped to his forehead that detects his smallest movement, Desikan moves a cursor around an on-screen keyboard. When he finds the letter he wants, he clicks a button with his right thumb, and it appears in a white space to the side. Repeating the process over and over, he debates research ideas with colleagues, analyzes reams of data and competes for grants. He types so much that he occasionally wears out the clicker. (McGinley, 6/13)
The Wall Street Journal:
The Mystery Around Middle-Age Suicides
The recent suicides of two well-known figures—celebrity chef Anthony Bourdain and fashion designer Kate Spade —underscore a sobering reality: Suicide rates for people in middle age are higher than almost any other age group in the U.S. and rising quickly. A report released today from the Centers for Disease Control and Prevention showed that suicide rates for women 45 to 64 increased nearly 60% between 2000 and 2016. For men of the same age the suicide rate increased almost 37% over that time. (Reddy, 6/14)
The New York Times:
6 Therapists, Psychiatrists And Counselors Talk About Treating The Suicidal
Last week provided two grim case studies in how fans, friends and family react to the suicides of beloved celebrities. It also provided a view into something far more obscure: the insights of mental health workers who are on the front line of America’s suicide crisis. As news of Kate Spade and Anthony Bourdain’s suicides emerged last week, mental health workers took to The New York Times’s comment section to describe what the crisis looks like to them. (Tessier, 6/13)
The New York Times:
That Huge Mediterranean Diet Study Was Flawed. But Was It Wrong?
The study was a landmark, one of the few attempts to rigorously evaluate a particular diet. And the results were striking: A Mediterranean diet, with abundant vegetables and fruit, can slash the risk of heart attacks and strokes. But now that trial, published in the New England Journal of Medicine in 2013, has come under fire. The authors retracted their original paper on Wednesday and published an unusual “re-analysis” of their data in the same journal. (Kolata, 6/13)
The Washington Post:
How Emoji Can Kill: As Gangs Move Online, Social Media Fuel Violence
Instead of tagging graffiti, some rival gang members now upload video of themselves chanting slurs in enemy territory. Taunts and fights that once played out over time on the street are these days hurled instantaneously on Twitter and Instagram. The online aggression can quickly translate into outbreaks of real violence — teens killing each other over emoji and virtually relayed gang signs. Social media have profoundly changed gang activity in the United States, according to a new report by a Chicago nonprofit. Of particular concern, researchers say, is how social media often appear to amplify and speed up the cycle of aggression and violence. (Wan, 6/13)